215 related articles for article (PubMed ID: 17612853)
21. The concepts of remission and recovery in schizophrenia.
Leucht S; Lasser R
Pharmacopsychiatry; 2006 Sep; 39(5):161-70. PubMed ID: 16944406
[TBL] [Abstract][Full Text] [Related]
22. Atypical antipsychotics in the treatment of mood disorders.
Jarema M
Curr Opin Psychiatry; 2007 Jan; 20(1):23-9. PubMed ID: 17143078
[TBL] [Abstract][Full Text] [Related]
23. Long-acting risperidone: focus on safety.
Möller HJ
Clin Ther; 2006 May; 28(5):633-51. PubMed ID: 16861087
[TBL] [Abstract][Full Text] [Related]
24. Paliperidone extended-release for the treatment of schizophrenia.
Marino J; Caballero J
Pharmacotherapy; 2008 Oct; 28(10):1283-98. PubMed ID: 18823223
[TBL] [Abstract][Full Text] [Related]
25. Antipsychotic agents in the treatment of bipolar mania.
Tohen M; Vieta E
Bipolar Disord; 2009 Jun; 11 Suppl 2():45-54. PubMed ID: 19538685
[TBL] [Abstract][Full Text] [Related]
26. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
27. Symptom domains of schizophrenia: the role of atypical antipsychotic agents.
Burton S
J Psychopharmacol; 2006 Nov; 20(6 Suppl):6-19. PubMed ID: 17046984
[TBL] [Abstract][Full Text] [Related]
28. Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychotics.
Kilian R; Dietrich S; Toumi M; Angermeyer MC
Acta Psychiatr Scand; 2004 Aug; 110(2):108-18. PubMed ID: 15233711
[TBL] [Abstract][Full Text] [Related]
29. Antipsychotic safety and efficacy concerns.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia.
Obradovic M; Mrhar A; Kos M
Int J Clin Pract; 2007 Dec; 61(12):1979-88. PubMed ID: 17997804
[TBL] [Abstract][Full Text] [Related]
31. Schizophrenia: multi-attribute utility theory approach to selection of atypical antipsychotics.
Bettinger TL; Shuler G; Jones DR; Wilson JP
Ann Pharmacother; 2007 Feb; 41(2):201-7. PubMed ID: 17311836
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Zink M; Kuwilsky A; Krumm B; Dressing H
J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
[TBL] [Abstract][Full Text] [Related]
33. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial.
Nasrallah HA
J Clin Psychiatry; 2007; 68 Suppl 1():5-11. PubMed ID: 17286522
[TBL] [Abstract][Full Text] [Related]
34. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
[TBL] [Abstract][Full Text] [Related]
35. Atypical antipsychotics in the treatment of delirium.
Peritogiannis V; Stefanou E; Lixouriotis C; Gkogkos C; Rizos DV
Psychiatry Clin Neurosci; 2009 Oct; 63(5):623-31. PubMed ID: 19674385
[TBL] [Abstract][Full Text] [Related]
36. New generation vs. first generation antipsychotics debate: pragmatic clinical trials and practice-based evidence.
Jakovljević M
Psychiatr Danub; 2009 Dec; 21(4):446-52. PubMed ID: 19935477
[TBL] [Abstract][Full Text] [Related]
37. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
38. Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
Leucht S; Kissling W; Davis JM
Psychol Med; 2009 Oct; 39(10):1591-602. PubMed ID: 19335931
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and effectiveness of first- and second-generation antipsychotics in schizophrenia.
Jaffe AB; Levine J
J Clin Psychiatry; 2003; 64 Suppl 17():3-6. PubMed ID: 14680419
[TBL] [Abstract][Full Text] [Related]
40. Treatment of schizophrenia patients: comparing new-generation antipsychotics to each other.
Fleischhacker WW; Widschwendter CG
Curr Opin Psychiatry; 2006 Mar; 19(2):128-34. PubMed ID: 16612191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
